🔗 Visit the ClinicalTrials.gov page for NCT00105443
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Sorafenib in advanced hepatocellular carcinoma. | N Engl J Med | 2008 | 54.30 |
| 2 | MicroRNA expression, survival, and response to interferon in liver cancer. | N Engl J Med | 2009 | 6.13 |
| 3 | Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. | Angiogenesis | 2014 | 2.07 |
| 4 | Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update. | Hepatol Res | 2012 | 1.24 |
| 5 | Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies. | Hepatology | 2013 | 0.86 |
| 6 | Targeting the tumor stroma in hepatocellular carcinoma. | World J Hepatol | 2015 | 0.86 |
| 7 | Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma. | Br J Cancer | 2011 | 0.83 |
| 8 | Clinical guideline SEOM: hepatocellular carcinoma. | Clin Transl Oncol | 2015 | 0.78 |
| 9 | Accomplishments in 2008 in the management of hepatobiliary cancers. | Gastrointest Cancer Res | 2009 | 0.76 |